Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 YearsBusiness Wire • 12/08/22
Pfizer, BioNTech ask FDA to authorize bivalent COVID vaccine in young childrenMarket Watch • 12/05/22
BioNTech, Vertex Pharmaceuticals And Other Big Biotechnology Stocks From Benzinga's Most Accurate Analysts - Beam Therapeutics (NASDAQ:BEAM), BioNTech (NASDAQ:BNTX)Benzinga • 12/02/22
BioNTech and Ryvu Therapeutics Enter into Global Collaboration to Develop and Commercialize Immuno-Modulatory Small Molecule CandidatesGlobeNewsWire • 11/30/22
BioNTech SE Sponsored ADR (BNTX) Just Overtook the 20-Day Moving AverageZacks Investment Research • 11/29/22
Pfizer and BioNTech updated booster shows strong results against new omicron sublineages in fresh analysis of dataMarket Watch • 11/18/22
Pfizer and BioNTech say bivalent booster increases neutralizing antibodies against new omicron variantsMarket Watch • 11/18/22
Pfizer and BioNTech Report New Data on Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Improved Immune Response Against Emerging Omicron SublineagesGlobeNewsWire • 11/18/22
Pfizer, BioNTech Take Next Step Toward A Pan-Covid Vaccine — But Is The Demand There?Investors Business Daily • 11/17/22
Pfizer and BioNTech Advance Next-Generation COVID-19 Vaccine Strategy with Study Start of Candidate Aimed at Enhancing Breadth of T cell Responses and Duration of ProtectionGlobeNewsWire • 11/16/22
Moderna Surges On New Omicron Data, Pulling Pfizer, BioNTech Along For The RideInvestors Business Daily • 11/14/22
BioNTech Expands Global Footprint by Acquiring GMP Manufacturing Site to Establish First mRNA Facility in SingaporeGlobeNewsWire • 11/14/22
Pfizer, BioNTech BA.4/BA.5-adapted booster gets CHMP recommendation for 5-11 year olds in EUMarket Watch • 11/10/22
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Children 5 Through 11 Years of Age in European UnionGlobeNewsWire • 11/10/22
BioNTech Takes A Hit Despite Doubling Profit Views, Raising 2022 OutlookInvestors Business Daily • 11/07/22
BioNTech profit and revenue fall sharply from year-ago period but top estimatesMarket Watch • 11/07/22